SFG
GILD icon

Sowa Financial Group’s Gilead Sciences GILD Stock Holding History

Sowa Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$32K – 242
2020
Q3 		$32K Sell
500
-50
-9% -$3.47K 0.02% 143
2020
Q2 		$42K Hold
550
– – 0.03% 131
2020
Q1 		$41K Buy
+550
New +$38K 0.04% 122

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sowa Financial Group's GILD Position: Q4 2020 in Review

Sowa Financial Group sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 500 shares — an estimated $32K sold.

Sowa Financial Group first reported a position in GILD in Q1 2020 and held it in 3 quarters. The position peaked at $42K in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Sowa Financial Group reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Sowa Financial Group sold 500 Gilead Sciences shares in Q4 2020, an estimated $32K.
  • Sowa Financial Group first reported a position in Gilead Sciences in Q1 2020 and held it in 3 quarters.
  • Sowa Financial Group's Gilead Sciences position peaked at $42K in Q2 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Sowa Financial Group's 13F filing for Q4 2020, filed 15 Jan 2021.